Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Impact of Disease on the Concept of End-of-life Decisions of the Elderly in the Community

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2012 by Meir Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
Meir Medical Center
ClinicalTrials.gov Identifier:
NCT01519622
First received: January 24, 2012
Last updated: January 26, 2012
Last verified: January 2012
  Purpose

The purpose of this study is to determine the priorities of the elderly in the community about end-of-life decisions. To check the perception of the disease in the elderly in the community.


Condition Intervention
Sick Elderly
Other: Questionnaire

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Prospective

Further study details as provided by Meir Medical Center:

Primary Outcome Measures:
  • Sick Elderly in the Community [ Time Frame: One year ] [ Designated as safety issue: No ]
    Questionnaires regarding end-of-life decisions and perception of illness


Estimated Enrollment: 88
Study Start Date: February 2012
Estimated Study Completion Date: January 2013
Estimated Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Sick elderly in community Other: Questionnaire
Questionnaire to be distributed among sick elderly in the community

Detailed Description:

This study is descriptive adapters which examines the relationship between illness perception and preferences of end of life decisions in the elderly in the community.

Population and sample: The target population will be elderly and healthy community elderly population was accessible due to a special branch of the club together in the center of the country. Sample to be a sample of convenience. The study will include 88 seniors aged 65 and over to get the power of 0.80 and alfa 0.05, Tools: The study used three tools.

  • The first tool is a questionnaire on demographic and clinical details
  • The second tool questionnaire the Long term support program (LTSP)
  • The third tool is a questionnaire perception of the disease Revised Illness Perceptions Questionnaire (IPQR)

The research process:

Investigator will present the proposal to the Commissioner Fund hospitals and request approval for the study. After receiving approval from the director Department of Health fund the hospital will make data collection phase HMO, days and hours of reception. Interrogator he is to partition the questionnaires and will be present when filling out the questionnaires to help, if and created a situation of lack of understanding of the questionnaires. Scholar, came to the population for the Disabled arriving at the clinic visit, and introduce himself and the subject of research. investigator will indicate questionnaire is anonymous.

  Eligibility

Ages Eligible for Study:   65 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Community sample

Criteria

Inclusion Criteria:

  • Chronic illness
  • Literate in Hebrew
  • Treated in community HMO

Exclusion Criteria:

  • Someone hospitalized in previous year
  • History of mental illness
  • Cognitive problems
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01519622

Contacts
Contact: Sheriff Khele, MA 972-50-6579668 sharifkh@clalit.org.il

Locations
Israel
Meir Medical Center Not yet recruiting
Kfar Saba, Israel
Principal Investigator: Sheriff Khele, MA         
Sub-Investigator: Ali Shalabi, RN, PhD         
Sponsors and Collaborators
Meir Medical Center
  More Information

No publications provided

Responsible Party: Meir Medical Center
ClinicalTrials.gov Identifier: NCT01519622     History of Changes
Other Study ID Numbers: K202/2011
Study First Received: January 24, 2012
Last Updated: January 26, 2012
Health Authority: Israel: Ministry of Health

Keywords provided by Meir Medical Center:
End of life decisions
Perception of illness

ClinicalTrials.gov processed this record on November 20, 2014